| Keratin gene mutations in disorders of human skin and its appendages JC Chamcheu, IA Siddiqui, DN Syed, VM Adhami, M Liovic, H Mukhtar Archives of biochemistry and biophysics 508 (2), 123-137, 2011 | 210 | 2011 |
| Anticancer properties of graviola (Annona muricata): a comprehensive mechanistic review I Rady, MB Bloch, RCN Chamcheu, S Banang Mbeumi, MR Anwar, ... Oxidative medicine and cellular longevity 2018, 2018 | 165 | 2018 |
| Role and therapeutic targeting of the PI3K/Akt/mTOR signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic agents therapy JC Chamcheu, T Roy, MB Uddin, S Banang-Mbeumi, RCN Chamcheu, ... Cells 8 (8), 803, 2019 | 159 | 2019 |
| Excellent anti-proliferative and pro-apoptotic effects of (−)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and … IA Siddiqui, DJ Bharali, M Nihal, VM Adhami, N Khan, JC Chamcheu, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (8), 1619-1626, 2014 | 154 | 2014 |
| Pomegranate extracts and cancer prevention: molecular and cellular activities D N Syed, JC Chamcheu, V M Adhami, H Mukhtar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 137 | 2013 |
| Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects DJ Bharali, IA Siddiqui, VM Adhami, JC Chamcheu, AM Aldahmash, ... Cancers 3 (4), 4024-4045, 2011 | 128 | 2011 |
| Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy V Sanna, CK Singh, R Jashari, VM Adhami, JC Chamcheu, I Rady, ... Scientific reports 7 (1), 41573, 2017 | 115 | 2017 |
| Impact of nanotechnology in cancer: emphasis on nanochemoprevention IA Siddiqui, VM Adhami, J Christopher, Chamcheu, H Mukhtar International journal of nanomedicine, 591-605, 2012 | 109 | 2012 |
| Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like … JC Chamcheu, VM Adhami, S Esnault, M Sechi, IA Siddiqui, KA Satyshur, ... Antioxidants & redox signaling 26 (2), 49-69, 2017 | 85 | 2017 |
| Chemical chaperones protect epidermolysis bullosa simplex keratinocytes from heat stress–induced keratin aggregation: involvement of heat shock proteins and MAP kinases JC Chamcheu, H Navsaria, I Pihl-Lundin, M Liovic, A Vahlquist, H Törmä Journal of Investigative Dermatology 131 (8), 1684-1691, 2011 | 85 | 2011 |
| Upregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model JC Chamcheu, MI Chaves-Rodriquez, VM Adhami, IA Siddiqui, GS Wood, ... Acta dermato-venereologica 96 (6), 854, 2016 | 73 | 2016 |
| Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment V Sanna, JC Chamcheu, N Pala, H Mukhtar, M Sechi, IA Siddiqui International journal of nanomedicine, 6835-6846, 2015 | 66 | 2015 |
| Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis JC Chamcheu, IA Siddiqui, VM Adhami, S Esnault, DJ Bharali, ... International journal of nanomedicine, 4189-4206, 2018 | 65 | 2018 |
| Fisetin, a 3, 7, 3′, 4′-tetrahydroxyflavone inhibits the PI3K/Akt/mTOR and MAPK pathways and ameliorates psoriasis pathology in 2D and 3D organotypic human inflammatory skin … JC Chamcheu, S Esnault, VM Adhami, AL Noll, S Banang-Mbeumi, T Roy, ... Cells 8 (9), 1089, 2019 | 63 | 2019 |
| Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin … JC Chamcheu, HC Pal, IA Siddiqui, VM Adhami, S Ayehunie, BT Boylan, ... Skin pharmacology and physiology 28 (4), 177-188, 2015 | 62 | 2015 |
| Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling DN Syed, JC Chamcheu, MI Khan, M Sechi, RK Lall, VM Adhami, ... Biochemical pharmacology 89 (3), 349-360, 2014 | 61 | 2014 |
| Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma DN Syed, RK Lall, JC Chamcheu, O Haidar, H Mukhtar Archives of biochemistry and biophysics 563, 108-117, 2014 | 59 | 2014 |
| Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise JC Chamcheu, GS Wood, IA Siddiqui, DN Syed, VM Adhami, JM Teng, ... Experimental dermatology 21 (7), 481-489, 2012 | 48 | 2012 |
| Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition JC Chamcheu, EP Lorié, B Akgul, E Bannbers, M Virtanen, L Gammon, ... Journal of dermatological science 53 (3), 198-206, 2009 | 45 | 2009 |
| Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis E Pavez Loriè, JC Chamcheu, A Vahlquist, H Törmä Archives of dermatological research 301, 475-485, 2009 | 43 | 2009 |
HASAN MUKHTARUniversity of Wisconsin-MadisonVerified email at wisc.edu
